D. Burke

62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases

V. R. McCready, R. Ott, M. Flower, 2001, European Journal of Nuclear Medicine.

Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases

T. Allen-Mersh, D. Burke, S. Earlam, 1995, The British journal of surgery.

Management of symptomatic locoregional recurrence during regional chemotherapy for colorectal liver metastases

D. Burke, M. Davies, C. Fordy, 1998, The British journal of surgery.

Basic Fibroblast Growth Factor Infusion Increases Tumour Vascularity, Blood Flow and Chemotherapy Uptake

P. Carnochan, C. Glover, T. Allen-Mersh, 2002, Acta oncologica.

Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre.

T. Allen-Mersh, D. Burke, S. Earlam, 1997, British Journal of Cancer.

Colorectal liver metastases.

T. Allen-Mersh, D. Burke, 1996, Postgraduate medical journal.

Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases

V. R. McCready, R. Ott, M. Flower, 2001, British Journal of Cancer.

Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model

P. Carnochan, C. Glover, T. Allen-Mersh, 2004, Clinical & Experimental Metastasis.

Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases.

C. Glover, T. Allen-Mersh, D. Burke, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases.

T. Allen-Mersh, D. Burke, S. Earlam, 1995, British Journal of Cancer.